Clinical trial · Interventional
Sexual Steroids: Relationship Between Serum and Prostatic Tissue Level
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients followed in the Foch Hospital Urology Department (Suresnes): Patients justifying a prostatectomy. * Patients justifying prostatectomy together with the bladder (radical cystectomy for bladder cancer). * Patients with benign prostate hyperplasia who justified a prostatectomy. Compare serum sexual steroid concentrations and intra-tissue on healthy prostates and prostate adenoma, assess concentrations intra-tissue sex steroids on cancer metastasis prostate specific blood sample under study (30mL) will be performed preoperatively in Patients followed in Foch Hospital Urology Department (Suresnes), and a Removal of a fragment of prostate tissue or metastasis will be analyze. Aim is to compare serum concentrations of sexual steroids and intra-tissue on healthy prostates and prostate adenomas compared to concentrations measured in patients operated for prostate cancer.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Hyperplasia | — | UNRESOLVED | — |
| Urinary Bladder Neoplasms | Bladder Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| steroids concentrations determination | Biological | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Bladder cancer
- description
- ▪ Patients justifying prostatectomy together with the bladder (radical cystectomy for bladder cancer).
- interventionNames
- Biological: steroids concentrations determination
- type
- OTHER
- label
- benign prostate hyperplasia
- description
- ▪ Patients with benign prostate hyperplasia who justified a prostatectomy.
- interventionNames
- Biological: steroids concentrations determination
Primary outcomes (1)
- measure
- Serum concentrations of sexual steroids and intra-tissue on healthy prostates
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Men aged over 18 years * Surgical indication justifying protatique prostatectomy, or complete prostatocystectomie, or removal of a metastasis of prostate cancer. * Patients affiliated to a social security scheme or benefiting from such a regime. * Patients who have given their consent to participate in writing Exclusion Criteria: * Patient received local therapy or hormonal treatment (LHRH analogue, therapy blocking androgen receptors) before surgery. * Treatment reductase inhibitors 5ARI ongoing or stopped for less than 3 months before the intervention. * Patient included in another clinical trial inconsistent with the conduct of this research. * Patient receiving treatment that could interfere with hormone levels (Prednisone, Ketoconazole, Abiraterone, Finasteride, Dutasteride).
References
Publications (0)
Data not yet available